NCT05319314 - GCC19CART for Patients With Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2024

Conditions

Colorectal Cancer

Interventions

DRUG

GCC19CART

Single infusion of Chimeric Antigen Receptor (CAR) transduced autologous T cells administered intravenously (i.v.)

Trial Locations (6)

NOT_YET_RECRUITING

University of Michigan Comprehensive Cancer Center, Ann Arbor

RECRUITING

Baylor Scott & White Research Institute, Dallas

RECRUITING

University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora

RECRUITING

City of Hope Comprehensive Cancer Center, Duarte

RECRUITING

University of California San Francisco Medical Center, San Francisco

RECRUITING

Dana-Farber Cancer Institute, Boston